Autres langues SMAIO

Actions

ALSMA

FR0014005I80

Produits pharmaceutiques

Marché Fermé - Euronext Paris 17:55:00 02/10/2026			Varia. 5j.	Varia. 1 janv.
6,660 ^EUR	-1,48%		-6,46%	+6,56%

16/07	SMAIO poursuit l'expansion de son réseau aux États-Unis avec 5 nouveaux centres et 13 chirurgiens ayant réalisé leurs premiers implants	CI
16/07	SMAIO franchit le cap des 5 millions d'euros de chiffre d'affaires au premier semestre

Autres langues

03/09	SMAIO has Reappointed Dr Donald J. Blaskiewicz to its Scientific Advisory Board in the United States
16/07	SMAIO Reports Group Sales Results for the Second Quarter and First Half Ended June 30, 2026
16/07	SMAIO Continued Expansion of the Network in the United States, with 5 New Centers Added to the Network and 13 New Surgeons Who Have Performed Their First Implants
16/07	SMAIO Reports Sales for the First Half of 2026
12/05	SMAIO : Quarterly financial reporting / First quarter financial report
12/05	SMAIO Reported Revenue of €2.8 Million in the First Quarter of 2026, an Increase of 11%
12/05	SMAIO Reports Unaudited Group Sales Results for the First Quarter of 2026
11/05	SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon
11/05	SMAIO Appoints Jeffrey M. Hills To North American Scientific Advisory Board
11/05	SMAIO : expands its North American Scientific Advisory Board with a new renowned surgeon
11/05	Weekly Earnings Calendar
05/05	SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating
27/04	S.M.A.I.O S.A. Reports Earnings Results for the Full Year Ended December 31, 2025
14/04	SMAIO Reports Strong FY 2025 Results, Amid Robust Growth in Activity
13/04	Weekly Earnings Calendar: JPMorgan and Netflix in the US, LVMH and ASML in Europe,
06/03	SMAIO : Inside Information / Operations of the issuer (acquisitions, sales...)
06/03	SMAIO Announces a €3.6 Million Capital Increase to Support Its Long-Term Growth Momentum
06/03	S.M.A.I.O S.A. announced that it expects to receive ?3.605287 million in funding
04/03	SMAIO : Informations privilégiées / Autres communiqués
04/03	SMAIO : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
20/01	SMAIO Reports Unaudited Group Sales Results for the Full Year Ended December 31, 2025
20/01	SMAIO Reports 2025 Sales of €9.2m, Representing an Increase of +67%
08/01	SMAIO: 2026 Financial Calendar
06/01	SMAIO Obtains ?2.0M in Non-Dilutive Financing
06/01	SMAIO Obtains €2.0m in Non-Dilutive Financing